General Instructions
Utilize Valzaar medication precisely as advised by your physician. Don’t take in more substantial amounts than prescribed. It is instructed to take these drugs at daytime to stop sleep disturbance.
Drink enough amount of water. Monitoring of kidney function and electrolytes levels is necessary while taking this medication. Report any adverse effects on the physician on priority. Do not stop the utilized of this tablet without consulting your physician.
When Not to Use?
Aliskiren
Coadministration of aliskiren and this combination of medication is not suggested due to the improved risk of severe side effects.
This risk is notably higher in the elderly population and patients with diabetes and kidney infections.
Allergy
This tablet is not suggested for utilizing in patients with a known allergy to hydrochlorothiazide, other sulfonamides, valsartan, or any other angiotensin receptor blockers.
Anuria
This tablet is not suggested for use in patients with anuria, a condition where the kidney is unable to produce urine.
Severe renal impairment
This medicine is not suggested or utilized in patients with severe renal impairment due to the improved risk of severe side effects.
General warnings
Hyperkalemia
Valzaar drugs may improve the potassium levels in the blood. This may cause serious adverse effects such as fatal cardiac rhythm irregularities. It is advised to avoid potassium-rich foods and other medication that may improve potassium levels during cure with these drugs.
Pediatric population
This medication is not suggested for utilized in children since the security and efficacy of use are not clinically established.
Hepatic dysfunction
This drugs should be used with extreme caution in patients suffering from liver diseases due to an increase in the risk of dangerous side effects. Close monitoring of liver function is instructed while taking these drugs. Report any symptoms of confusion or jaundice to the physician on priority. Replacement with a suitable different may be required based on the health situation.
Volume and electrolyte depletion
This tablet may alter the blood volume and electrolyte levels in some patients. This may cause dry mouth, dizziness, and acid-base imbalance. This risk is mostly higher in patients suffering from kidney and liver infection. A close watch of blood pressure and electrolyte levels is suggested for such patients. Proper dose adjustments or replacement with a suitable alternative may be required based on the clinical situation.
Severe renal impairment
This medication is not suggested for use in patients with a known history of severe renal impairment due to the improved risk of worsening of the patient's situation.
Renal artery stenosis
This medicine is not suggested or use in patients with a known history of renal artery stenosis since it may aggravate the patient's condition.
Driving and operating machines
Valzaar medicine may cause dizziness or drowsiness in some patients. It is advised that you do not execute any activities that require high mental alertness like driving a vehicle or operating machinery if you experience these symptoms during treatment with this medicine.
Warnings for special population
Pregnancy
This medicine is not suggested for utilized in pregnant women except in life-threatening situations. All the risks and benefits should be discussed with the doctor before taking these drugs. Your doctor may prescribe a safer option based on your health situation.
Breastfeeding
This medicine is not suggested for utilized in breastfeeding women unless necessary. All the risks and benefits should be discussed with the physician before taking these drugs. Your physician may advise you to discontinue breastfeeding or to discontinue the drug based on your clinical situation.
